Changes in Microbiota and Metabolomic Profile Between Rifaximin Responders and Non-responders In Diarrhoea-Predominant Irritable Bowel Syndrome
Clinical trial NCT03557788 · COMPLETED
Trial details
- NCT number
- NCT03557788
- Sponsor
- National University Hospital, Singapore
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2018-05-07
- Primary completion
- 2021-08-13
- Enrollment
- 33
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.